Avidity Biosciences Inc
(RNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -447,530 | -273,088 | -115,773 | -322,302 | -220,045 |
| Depreciation Amortization | -8,382 | -7,033 | -4,372 | -18,671 | -12,243 |
| Other Working Capital | -81,930 | -81,414 | -23,244 | -14,557 | -8,394 |
| Other Operating Activity | 57,174 | 37,040 | 18,560 | 54,660 | 39,683 |
| Operating Cash Flow | $-480,668 | $-324,495 | $-124,829 | $-300,870 | $-200,999 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -234,270 | 349,769 | 160,941 | -847,135 | -786,879 |
| PPE Investments | -10,983 | -7,096 | -3,753 | -7,066 | -3,150 |
| Investing Cash Flow | $-245,253 | $342,673 | $157,188 | $-854,201 | $-790,029 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 856,076 | 5,710 | 1,937 | 1,192,357 | 1,178,633 |
| Financing Cash Flow | $856,076 | $5,710 | $1,937 | $1,192,357 | $1,178,633 |
| Exchange Rate Effect | 138 | 154 | 39 | N/A | N/A |
| Beginning Cash Position | 222,663 | 222,663 | 222,663 | 185,377 | 185,377 |
| End Cash Position | 352,956 | 246,705 | 256,998 | 222,663 | 372,982 |
| Net Cash Flow | $130,293 | $24,042 | $34,335 | $37,286 | $187,605 |
| Free Cash Flow | |||||
| Operating Cash Flow | -480,668 | -324,495 | -124,829 | -300,870 | -200,999 |
| Capital Expenditure | -10,983 | -7,096 | -3,753 | -7,066 | -3,150 |
| Free Cash Flow | -491,651 | -331,591 | -128,582 | -307,936 | -204,149 |